Artemis Medicare Services
285.46
-0.68(-0.24%)
Market Cap₹3,965.96 Cr
PE Ratio47.21
Company Performance:
1D-0.24%
1M+16.68%
6M+4.22%
1Y-13.89%
5Y+1,522.85%
View Company Insightsright
More news about Artemis Medicare Services
18Sept 25
Artemis Medicare Services Appoints Rudra Narayan Acharjee as Head of Investor Relations and Growth Strategy
Artemis Medicare Services Limited has appointed Mr. Rudra Narayan Acharjee as Head-Investor Relations, M&A and Organization Growth Strategy, effective September 18, 2025. Mr. Acharjee, a CFA and MBA holder, brings extensive experience from healthcare, manufacturing, and banking sectors. His role will involve leading investor relations, overseeing M&A activities, and developing growth strategies. This appointment aims to strengthen the company's leadership and drive expansion plans.
06Aug 25
Artemis Medicare Unveils Ambitious Expansion Plan, Reports Strong Q1 Performance
Artemis Medicare Services plans to increase bed capacity to over 1,100 by FY26, adding a 300-bed hospital in Raipur and a 550-bed hospital in South Delhi. Q1 financial results show significant growth with ARPOB reaching ₹83,900, PAT growing 28%, gross revenue up 14.4% to ₹2,681.00 crore, and EBITDA rising 19.1% to ₹483.00 crore. Operational metrics improved with 61.2% occupancy rate and increased patient volumes. The company is focusing on capacity enhancement, super specialty expansion, an asset-light model, and international growth.
05Aug 25
Artemis Medicare Services Reports Strong Q1 Growth, Utilizes Rs 54 Crore from Debenture Issue
Artemis Medicare Services Limited announced robust Q1 financial results with consolidated gross revenue up 14.40% YoY to Rs 2,681.00 crore. Net profit grew by 28.20% to Rs 212.00 crore. The company's flagship hospital in Gurgaon showed impressive metrics with ARPOB reaching Rs 83,900.00. Artemis also reported on the utilization of proceeds from its Rs 330.00 crore Preferential Issue of Compulsorily Convertible Debentures, with Rs 54.00 crore utilized and Rs 268.06 crore unutilized. The company highlighted strategic developments including new bed additions, signing of an MoU for a Medical Services Agreement, launch of India's first private Geriatrics & Longevity Department, and a partnership for heart-lung transplants.
05Aug 25
Artemis Medicare Services Reports Strong Q1 FY26 Growth with 14.2% Revenue Surge
Artemis Medicare Services Limited reported robust Q1 FY26 results. Consolidated net revenue increased 14.2% to ₹254.96 crore. Net profit rose 28.3% to ₹21.20 crore. EBITDA grew 19.1% to ₹48.30 crore with a 19.0% margin. International patient revenue surged 31.4% to ₹70.40 crore. The company added new beds, signed an MoU for expansion in North India, launched a Geriatrics & Longevity Department, and partnered with KIMS for heart-lung transplants. 13,30,000 equity shares were issued under the management stock option plan.
12May 25
Artemis Medicare Reports Mixed Q4 Results: Profit Surges Despite EBITDA Decline
Artemis Medicare Services Ltd released its Q4 FY2024 financial results, showing a 6.22% increase in revenue to ₹239.00 crore and a 62.00% surge in net profit to ₹230.00 crore. However, EBITDA declined by 5.53% to ₹359.00 crore, with margin contracting to 14.96%. Annual performance was strong with revenue up 18.94% to ₹885.90 crore and net profit growing 29.21% to ₹49.10 crore.
Artemis Medicare Services
285.46
-0.68
(-0.24%)
1 Year Returns:-13.89%
Industry Peers
Max Healthcare Institute
1,162.80
(+0.09%)
Apollo Hospitals
7,335.50
(+0.18%)
Fortis Healthcare
919.10
(-0.33%)
Narayana Hrudayalaya
1,945.50
(-0.29%)
Aster DM Healthcare
665.45
(-0.03%)
Global Health
1,246.00
(-0.32%)